Literature DB >> 11229356

Ironing-out mechanisms of neuronal injury under hypoxic-ischemic conditions and potential role of iron chelators as neuroprotective agents.

F A Sorond1, R R Ratan.   

Abstract

Iron is the most abundant transition metal in the brain, where it functions as an important cofactor in a host of vital metabolic processes and plays an absolutely essential role in cell viability. Free iron is also very toxic when present in high concentrations, thus placing this essential metal at the core of neurotoxic injury in a number of neurological disorders. The pivotal role of iron in cellular homeostasis, including its latent toxicity, necessitates a tight regulation of iron metabolism. Oxygen and iron appear to play an important role in iron homeostasis. They appear to exert their homeostatic role by modulating the proteins involved in a complex interplay between iron sensing, transport, and storage. These key regulatory proteins include ferritin (intracellular storage), transferrin (extracellular transport), transferrin receptor, and iron regulatory protein (sensor of intracellular iron concentration). The interplay of iron and oxygen is most intriguing in the setting of stroke, where hypoxia and free iron appear to interact in causing the subsequent neuronal death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11229356     DOI: 10.1089/15230860050192206

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  14 in total

1.  PKA modulates iron trafficking in the striatum via small GTPase, Rhes.

Authors:  Bo-Ran Choi; Sookhee Bang; Yong Chen; Jaime H Cheah; Sangwon F Kim
Journal:  Neuroscience       Date:  2013-08-30       Impact factor: 3.590

Review 2.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Antioxidant activities of seabuckthorn (Hippophae rhamnoides) during hypoxia induced oxidative stress in glial cells.

Authors:  S Narayanan; D Ruma; B Gitika; S K Sharma; T Pauline; M Sai Ram; G Ilavazhagan; R C Sawhney; D Kumar; P K Banerjee
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

Review 4.  Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions.

Authors:  Linnea R Freeman; Jeffrey N Keller
Journal:  Biochim Biophys Acta       Date:  2011-12-20

Review 5.  Central nervous system agents for ischemic stroke: neuroprotection mechanisms.

Authors:  Rachna S Pandya; Lijuan Mao; Hua Zhou; Shuanhu Zhou; Jiang Zeng; A John Popp; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2011-06-01

6.  Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells.

Authors:  Eldi Schonfeld; Ilanit Yasharel; Ephraim Yavin; Annette Brand
Journal:  Neurochem Res       Date:  2007-06-06       Impact factor: 3.996

7.  Ferrous citrate up-regulates the NOS2 through nuclear translocation of NFκB induced by free radicals generation in mouse cerebral endothelial cells.

Authors:  Li-Ching Chen; Chin Hsu; Chuang Chin Chiueh; Wen-Sen Lee
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

8.  Hepcidin is involved in iron regulation in the ischemic brain.

Authors:  Hui Ding; Cai-Zhen Yan; Honglian Shi; Ya-Shuo Zhao; Shi-Yang Chang; Peng Yu; Wen-Shuang Wu; Chen-Yang Zhao; Yan-Zhong Chang; Xiang-Lin Duan
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

9.  Desferroxamine infusion increases cerebral blood flow: a potential association with hypoxia-inducible factor-1.

Authors:  Farzaneh A Sorond; Michele L Shaffer; Andrew L Kung; Lewis A Lipsitz
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

10.  Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging: Potential Role for Hypoxia-Inducible Transcription Factor-1-Regulated Pathways.

Authors:  Farzaneh A Sorond; Can Ozan Tan; Sarah LaRose; Andrew D Monk; Raina Fichorova; Stanthia Ryan; Lewis A Lipsitz
Journal:  Stroke       Date:  2015-07-30       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.